JAK2 and precursor B-cell acute lymphoblastic leukemia: Next, to further validate our in vivo B-ALL results, we generated pure, clonal populations of leukemic cells deficient in Ifngr1, Jak2, or Stat1 (Supplementary Fig. 5a).